BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27388586)

  • 1. Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.
    Aoki J; Sakamoto Y; Kimura K
    J Neuroimaging; 2016 Jul; 26(4):414-9. PubMed ID: 27388586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.
    Kawano H; Hirano T; Inatomi Y; Terasaki T; Yonehara T; Uchino M
    Cerebrovasc Dis; 2010 Aug; 30(3):230-6. PubMed ID: 20606424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
    Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
    Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
    Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
    Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke.
    Mikulik R; Ribo M; Hill MD; Grotta JC; Malkoff M; Molina C; Rubiera M; Delgado-Mederos R; Alvarez-Sabin J; Alexandrov AV;
    Circulation; 2007 May; 115(20):2660-5. PubMed ID: 17502578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.
    Singer OC; Berkefeld J; Lorenz MW; Fiehler J; Albers GW; Lansberg MG; Kastrup A; Rovira A; Liebeskind DS; Gass A; Rosso C; Derex L; Kim JS; Neumann-Haefelin T;
    Cerebrovasc Dis; 2009; 27(4):368-74. PubMed ID: 19218803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IV vs. IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study.
    Sen S; Huang DY; Akhavan O; Wilson S; Verro P; Solander S
    Neurocrit Care; 2009; 11(1):76-81. PubMed ID: 19277904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.
    Thomalla G; Schwark C; Sobesky J; Bluhmki E; Fiebach JB; Fiehler J; Zaro Weber O; Kucinski T; Juettler E; Ringleb PA; Zeumer H; Weiller C; Hacke W; Schellinger PD; Röther J;
    Stroke; 2006 Mar; 37(3):852-8. PubMed ID: 16439696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
    Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
    Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis.
    Ribo M; Molina CA; Alvarez B; Rubiera M; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2010 Jul; 20(3):224-7. PubMed ID: 19226340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.
    Daffertshofer M; Gass A; Ringleb P; Sitzer M; Sliwka U; Els T; Sedlaczek O; Koroshetz WJ; Hennerici MG
    Stroke; 2005 Jul; 36(7):1441-6. PubMed ID: 15947262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.
    Röther J; Schellinger PD; Gass A; Siebler M; Villringer A; Fiebach JB; Fiehler J; Jansen O; Kucinski T; Schoder V; Szabo K; Junge-Hülsing GJ; Hennerici M; Zeumer H; Sartor K; Weiller C; Hacke W;
    Stroke; 2002 Oct; 33(10):2438-45. PubMed ID: 12364735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and sonographic patterns of tandem internal carotid artery/middle cerebral artery occlusion in tissue plasminogen activator-treated patients.
    El-Mitwalli A; Saad M; Christou I; Malkoff M; Alexandrov AV
    Stroke; 2002 Jan; 33(1):99-102. PubMed ID: 11779896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and tissue response to intravenous thrombolysis in tandem internal carotid artery/middle cerebral artery occlusion: an MRI study.
    Thomalla G; Kruetzelmann A; Siemonsen S; Gerloff C; Rosenkranz M; Röther J; Fiehler J
    Stroke; 2008 May; 39(5):1616-8. PubMed ID: 18323483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset.
    Han MK; Kim SH; Ko SB; Paik NJ; Kwon OK; Lee YS; Oh CW; Kim JH; Park SH; Bae HJ
    Neurocrit Care; 2008; 8(3):353-9. PubMed ID: 18340411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.
    Parsons MW; Christensen S; McElduff P; Levi CR; Butcher KS; De Silva DA; Ebinger M; Barber PA; Bladin C; Donnan GA; Davis SM;
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1214-25. PubMed ID: 20087363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.